Prudential Financial’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Prudential Financial’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-8,375	Closed	-$312K	–	2648
2021 Q2	$312K	Sell	8,375 -162	-2%	-$4.96K	﹤0.01%	2293
2021 Q1	$218K	Sell	8,537 -101,687	-92%	-$2.6M	﹤0.01%	2382
2020 Q4	$2.43M	Sell	110,224 -318,926	-74%	-$7.02M	﹤0.01%	1328
2020 Q3	$7.72M	Buy	429,150 +68,844	+19%	+$1.43M	0.01%	767
2020 Q2	$9.15M	Buy	360,306 +256,673	+248%	+$5.53M	0.02%	726
2020 Q1	$1.9M	Buy	103,633 +63,260	+157%	+$1.23M	﹤0.01%	1379
2019 Q4	$890K	Buy	+40,373	New	+$812K	﹤0.01%	1899

Other funds holding DRNA

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Prudential Financial's DRNA Position: Q3 2021 in Review

Prudential Financial sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q3 2021, closing a stake of 8,375 shares — an estimated $312K sold.

Prudential Financial first reported a position in DRNA in Q4 2019 and held it in 7 quarters. The position peaked at $9.15M in Q2 2020. 173 funds tracked by Wall St. Rank hold DRNA as of Q3 2021.

Prudential Financial reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Prudential Financial sold 8,375 Dicerna Pharmaceuticals, Inc. shares in Q3 2021, an estimated $312K.
Prudential Financial first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2019 and held it in 7 quarters.
Prudential Financial's Dicerna Pharmaceuticals, Inc. position peaked at $9.15M in Q2 2020.
173 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q3 2021.

Based on Prudential Financial's 13F filing for Q3 2021, filed 15 Nov 2021.